The FDA is evaluating the risk of Medtronic (NYSE:MDT) silicone-based electromyogram (EMG) endotracheal tubes following reports of deaths and serious adverse events.
The FDA issued the warning last week in a letter to healthcare providers concerning the Medtronic NIM Standard Reinforced EMG Endotracheal Tubes and Medtronic NIM Contact Reinforced EMG Endotracheal Tubes. They are the only silicone-based EMG tubes currently sold in the U.S.
The FDA said there is a risk of airway obstruction, ventilation failure, oxygen deprivation and death from the 510(k)-cleared tubes, which provide an airway during surgery and use electrodes to monitor nerves to the laryngeal musculature when connected to an EMG monitor.